Citius Oncology, Inc. CTOR Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$26.61M-244% | -$5.53M+16.9% | -$5M+26.7% | -$5.37M-12.5% | -$7.74M-60.0% | ||
| $3.53M+68.9% | $3.96M+119% | $2.3M+37.8% | $2.13M+8.6% | $2.09M+6.7% | ||
| —— | $264.24K0.0% | $264.24K+83.5% | $264.24K+83.5% | $264.24K+83.5% | ||
| —— | $4.05M— | —— | —— | —— | ||
| $20.25K-97.9% | $352.65K-94.2% | $3.71M+595% | $1.87M+250% | $957.88K+79.6% | ||
| -$1.56M-187% | -$2.79M-229% | $4.57M+23.1% | $991.11K+297% | $1.8M+503% | ||
| $19.54M+684% | $425.79K-93.2% | —— | —— | $2.49M+2,119% | ||
| —— | $1.83M— | —— | —— | —— | ||
| -$3.83M-179% | -$7.35M-436% | -$1.37M-301% | -$1.37M-4,447% | -$1.37M-616% | ||
| $600K-58.3% | $4.4M+206% | $1.44M+15.0% | $1.44M+15.0% | $1.44M+15.0% | ||
| —— | $40M+2,393% | $1.6M-95.2% | $1.6M— | $1.6M— | ||
| -$600K+58.3% | -$4.4M-206% | -$1.44M+95.2% | -$1.44M-15.0% | -$1.44M-106% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $20M-60.0% | —— | —— | ||
| —— | $15.13M— | $15.17M— | —— | —— | ||
| —— | $15.13M+299% | $3.79M-87.0% | $3.79M+211% | $3.79M+115% | ||
| -$4.66M-575% | $3.37M+244% | $981.2K+538% | $981.2K— | $981.2K+167,914% | ||
| —— | $14.46K-69.1% | $46.85K— | $46.85K— | $46.85K— | ||
| $1.72M— | $573.44K— | —— | —— | —— | ||
| -$1.56M-187% | -$2.79M-229% | $4.57M+23.1% | $991.11K+297% | $1.8M+503% | ||
| -$3.27M-260% | $1.98M-14.2% | $2.05M-27.4% | $2.52M-34.1% | $2.05M— | ||
| —— | $1.83M— | —— | —— | —— | ||
| —— | $2.75M0.0% | —— | —— | —— | ||
| —— | $40M— | —— | —— | —— | ||
| $600K-58.3% | $4.4M+206% | $1.44M+15.0% | $1.44M+15.0% | $1.44M+15.0% | ||
| —— | —— | $20M-60.0% | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $328.88K— | $789.21K— | —— | —— | —— | ||
| -$0.27-145% | -$0.06+33.3% | -$0.06+40.0% | -$0.08-14.3% | -$0.11-57.1% | ||
| —— | —— | 6.3%+0.2% | —— | —— | ||
| $1.76M— | —— | —— | —— | —— | ||
| $23.63M+953% | $2.86M-13.9% | $1.34M-63.9% | $1.88M+22.1% | $2.24M+61.9% | ||
| $1.34M— | $3.15M— | —— | —— | —— | ||
| -$26.84M-259% | -$5.27M+17.6% | -$4.73M+29.0% | -$5.11M-10.3% | -$7.47M-59.3% | ||
| —— | —— | $54.51K— | $54.51K— | $54.51K— | ||
| $33.03K— | $45.84K— | $57.28K— | $160.76K— | —— | ||
| $43.72K+381% | $28.29K+211% | $9.09K— | $9.09K— | $9.09K— | ||
| $1.77M+4,003% | -$17.55K+61.3% | -$45.41K— | -$45.41K— | -$45.41K— | ||
| $27.94K-8.0% | $27.94K-8.0% | $27.94K-8.3% | $27.94K-8.0% | $30.37K+8.7% | ||
| $469K-2.3% | $480K0.0% | $480K-0.3% | $480K-6.9% | $480K-0.6% | ||
| —— | —— | —— | —— | —— | ||
| $1.67M— | $3.94M— | —— | —— | —— | ||
| —— | —— | 85%-2.0% | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | 0%— | —— | —— | ||
| —— | —— | 11.6M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $342.18K-77.7% | $342.18K-77.7% | $342.18K-77.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Citius Oncology, Inc. generate?
- Citius Oncology, Inc. (CTOR) generated -$13.9M in operating cash flow over the trailing twelve months.
- Where does Citius Oncology, Inc.'s cash flow data come from?
- Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.